In my last post, I briefly touched on COVID-19 and older adults. In this post, I will take a short, basic data tour of the skilled nursing home COVID-19 data made available by the CDC. COVID-19 and Nursing Homes Late February, in Washington state, Stat News reported the first COVID-19... read more →
COVID-19 and Black, Hispanic, and Indigenous People Last month, Americans were protesting against the stay-at-home orders in the name of opening the economy as unemployment rates steadily increased. Looking at Twitter, you’ll see many tweets like the one below, pining to reopen. People are aching to go back to “normal.”... read more →
While pharma marketers continue to navigate their brand through COVID-19, non-personal promotion appears to be the best approach for the time being. In order to reach optimal efficiency, marketers will want to utilize the best list of providers for their brand. Publicly available datasets, as well as commercially available datasets,... read more →
On March 9th, 2020, HHS Office of the National Coordinator for Health Information Technology (ONC) and Centers for Medicare & Medicaid Services (CMS) finalized two open data rules: CMS’ interoperability and patient access rule ONC’s Cures Act Hosted by Ogilvy Consulting, several industry leaders discussed the new rules and what... read more →
People are talking about hydroxychloroquine and coronavirus. And others are looking to grab some for personal use. But what is it, and can it help the thousands of people currently fighting the virus? What is Hydroxychloroquine? The Centers for Disease Control and Prevention (CDC) describes chloroquine as a medicine... read more →
What is CAR T-cell Therapy? CAR T-cell therapy is immunotherapy. Physicians extract one type of white blood cell, the T-cell, copious amounts of these cells from the patient’s blood. Then, an inactive virus is inserted into the cell, specifically to place a gene in the cell. Next, the T-cell produces... read more →
This year Academy Health co-located the National Health Policy Conference with Health Datapalooza. It was well executed. There were lots of great concurrent break-out sessions. Because of that, people had a hard time choosing which health data and policy sessions to attend. Some chose to divide their time between... read more →
This is my final post in the series covering the Hospital Price Transparency Executive Order. CMS recently proposed guidelines for how hospitals should list their standard charges to the public, as required by the Executive Order. I submitted comments to CMS on this portion of the proposed rule because of... read more →
My last blog in the series was Predicting Out-of-Pocket Patient Expenses. President Trump signed the Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First. CMS is currently requesting comments on its plan for implementing this order in... read more →
The previous blog, Transparent and machine-readable prices (and surprise medical billing) was the second in a series on the Hospital Price Transparency Executive Order. President Trump signed the Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First. CMS is currently requesting comments on its plan for implementing this... read more →